Bumper Offer - Urjas oil Just @ Rs. 1
Gemcal DS Soft Gelatin Capsule (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Gemcal DS Soft Gelatin Capsule (15) is used -
Severe
Is the use of Gemcal DS Soft Gelatin Capsule (15) safe for pregnant women?
Gemcal is safe to take during pregnancy.
Is the use of Gemcal DS Soft Gelatin Capsule (15) safe during breastfeeding?
Gemcal is safe for breastfeeding women.
What is the effect of Gemcal DS Soft Gelatin Capsule (15) on the Kidneys?
Gemcal does not damage the kidneys.
What is the effect of Gemcal DS Soft Gelatin Capsule (15) on the Liver?
Gemcal is completely safe for the liver.
What is the effect of Gemcal DS Soft Gelatin Capsule (15) on the Heart?
Gemcal is not harmful for the heart.
Gemcal DS Soft Gelatin Capsule (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemcal DS Soft Gelatin Capsule (15) unless your doctor advises you to do so -
Is this Gemcal DS Soft Gelatin Capsule (15) habit forming or addictive?
No, you will not get addicted to Gemcal DS Soft Gelatin Capsule (15).
Interaction between Food and Gemcal DS Soft Gelatin Capsule (15)
You can take Gemcal DS Soft Gelatin Capsule (15) with food.
Interaction between Alcohol and Gemcal DS Soft Gelatin Capsule (15)
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemcal DS Soft Gelatin Capsule (15) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 265-269
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 655
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1276-1278
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 340-342
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rocaltrol® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Calcijex® (calcitriol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pentetate zinc trisodium injection (Zn-DTPA)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 680